Advanced Therapies Intelligence: Gene therapy, cell therapy and advanced-therapies intelligence

Advanced Therapies Intelligence brings together the HERMS solutions that address one shared business problem within the governed HERMS life-sciences intelligence platform.

The business problem

Complex translational evidence across gene therapy, cell therapy, exosomes and experimental design requires structured, traceable evaluation.

HERMS solutions in this domain

How these solutions connect

Solutions in this domain share evidence and governance with the rest of the HERMS platform, so decisions stay traceable and open to accountable human review. HERMS provides decision support and does not replace qualified professional, regulatory or clinical judgement.

Book a working session

Other intelligence domains

ENGINEERING INTELLIGENCE. REVOLUTIONIZING LIFE SCIENCES.

HERMS is the intelligence platform. Its applications are the decision engines. HERMS expert services support implementation and regulated execution of the HERMS intelligence ecosystem, from regulatory and market access to pharmacovigilance, compliance and quality.

Drug registration timelines by country · SFDA, MOHAP, EDE, EDA, EMA and FDA timelines · GCC central registration